article thumbnail

Traditional Meat Industry’s Beef With Alternative Protein Continues with the FAIR on Labels Act

The FDA Law Blog

Many individual states have pursued some type of legislation to restrict the use of traditional meat terminology for the labeling of APPs. Many states have proposed but failed to enact legislation regulating the labeling of APPs, in some cases due to concerns of potential legal challenges based on federal preemption claims.

article thumbnail

FDA-Approved Labeling: Is Enough Enough?

The FDA Law Blog

Livornese — I saw the sign…and the answer is no—FDA-approved labeling apparently is not enough under state failure-to-warn laws, according to certain courts. A recent state law failure-to-warn case in the SDNY makes that very point.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Chick-fil-A drops a ‘No Antibiotic Ever’ pledge on chicken over supply issues

STAT

Notably, Tyson Foods, which is one of the biggest poultry suppliers, a few months ago removed the “No Antibiotics Ever” label from its chickens after reportedly encountering higher costs. Continue to STAT+ to read the full story…

Labelling 132
article thumbnail

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

pharmaphorum

The case hinges around the concept of “ skinny labelling ” which was introduced to stop drugmakers extending the exclusivity period for their branded medicines – through a stream of new indications or patient populations – that can be protected with so-called “use” patents. The substance patent expired in 2007.

article thumbnail

Look out, Teva. Neurocrine's Ingrezza wins Huntington's disease FDA nod to rival Austedo

Fierce Pharma

Ingrezza was first approved in tardive dyskinesia in 2017. With its second approval, the medication’s label now largely stacks up to Teva Pharmaceuticals’ Austedo. . | The FDA approved Ingrezza capsules to treat adult with chorea associated with Huntington’s disease.

FDA 96
article thumbnail

The End of the Road for the Skinny Label?

The FDA Law Blog

We previously noted that “ the skinny label may be dead ” and, while we still can’t be sure if it’s truly gone (but not forgotten), we now know that the Supreme Court won’t hear this case at this time. So, while the skinny label may not actually be dead, there will certainly be a reluctance to use it.

article thumbnail

STAT+: A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk

STAT

Boger, 72, founded Vertex in 1989 and served in various roles until 2017. The clear column in his kitchen filled with racks of wine still holds a Vertex-labeled wine bottle.) He was involved in many of the turning points that led to Friday’s landmark approval, but he still finds it hard to believe.

Labelling 131